Abstract | BACKGROUND AND PURPOSE:
Intracranial hemorrhage has been observed in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19), but the clinical, imaging, and pathophysiological features of intracranial bleeding during COVID-19 infection remain poorly characterized. This study describes clinical and imaging characteristics of patients with COVID-19 infection who presented with intracranial bleeding in a European multicenter cohort. METHODS: This is a multicenter retrospective, observational case series including 18 consecutive patients with COVID-19 infection and intracranial hemorrhage. Data were collected from February to May 2020 at five designated European special care centers for COVID-19. The diagnosis of COVID-19 was based on laboratory-confirmed diagnosis of SARS-CoV-2. Intracranial bleeding was diagnosed on computed tomography (CT) of the brain within one month of the date of COVID-19 diagnosis. The clinical, laboratory, radiologic, and pathologic findings, therapy and outcomes in COVID-19 patients presenting with intracranial bleeding were analyzed. RESULTS: CONCLUSION: This study represents the largest case series of patients with intracranial hemorrhage diagnosed with COVID-19 based on key European countries with geospatial hotspots of SARS-CoV-2. Isolated SAH along the convexity may be a predominant bleeding manifestation and may occur in a late temporal course of severe COVID-19.
|
Authors | Jawed Nawabi, Andrea Morotti, Moritz Wildgruber, Gregoire Boulouis, Hermann Kraehling, Frieder Schlunk, Elif Can, Helge Kniep, Götz Thomalla, Marios Psychogios, Bernd Hamm, Jens Fiehler, Uta Hanning, Peter Sporns |
Journal | Journal of clinical medicine
(J Clin Med)
Vol. 9
Issue 8
(Aug 06 2020)
ISSN: 2077-0383 [Print] Switzerland |
PMID | 32781623
(Publication Type: Journal Article)
|